Drug thangs Flashcards
Omalizumab
IgE
Prevents IgE from binding to its receptor
Allergic asthma
Cetuximab
EGFR
Stage IV CRC, head and neck cancer
RANKL mab
Denosumab
Prevents IgE binding to its receptor
Omalizimuab
MAB that inhibits neutrophil adhesion
Natalizumab (alpha4-integrin)
Avoid in pregnancy due to gray baby syndrome
Chloramphenicol
Avoid in pregnancy due to kernicterus
Sulfas (severe jaundice)
Avoid in pregnancy due to dicolored teeth/bones
Tetracyclines
Natalizumab
Alpha4-integrin
MS, Chron’s
Increased risk of PML
Infliximab
TNFalpha
IBD/RA/ankylosing spondylitis/psoriasis
RSF F protein mab
Palivizumab
HER2/neu mab
Trastuzumab
MAB that can causes PML
Natalizumab
Antidote that is a mab
Digoxin immune Fab
Avoid in pregnancy due to teratogenic effects
Griseofulvin
Ribavirin
CD20 mab
Rituximab
Avoid in pregnancy due to ototoxicity
Aminoglycosides
Palivizumab
RSV F protein
Prevents RSV in high-risk infants
EGFR mab
Cetuximab
MAB for CLL
Alemtuzumab (CD52)
CD52 mab
Alemtuzumab
Bevacizumab
VEGF
CRC, renal cell carcinoma
MAB for osteoporosis
Denosumab (RANKL)
GpIIb/IIIa mab
Abciximab
Trastuzumab
HER2/neu
Breast CA, gastric CA
Adalimumab
CD20
RA/IBD/ankylosing spondylitis/psoriasis
Avoid in pregnancy due to embryotoxic effects
Clarithromycin
Abciximab
GpIIb/IIIa
Prevents fibrinogen binding = no platelet aggregation
Prevention of ischemia in patients undergoing coronary interventions
Patient with MS or Chron’s develops rapidly progressive neuro signs
Think natalizumab = increased risk of PML
Alemtuzumab
CD52
CLL
(aLYMtuzumab)
TNFalpha mab
Infliximab
Adalimumab
Avoid in pregnancy due to cartilage damage
Fluoroquinolones
8 antibiotics to avoid in pregnancy
Sulfas
Aminoglycosides
Chloramphenicol
Griseofulvin
Ribavirin
Tetracyclines
Clarithromycin
Fluoroquinolones
VEGF mab
Bevacizumab
IgE mab
Omalizumab
Denosumab
RANKL
Inhibits osteoclast activation
Osteoporosis
Alpha4-integrin mab
Natalizumab
Rituximab
CD20
RA (+ MTX), B cell lymphoma, ITP